Mason Street Advisors’s Sabra Healthcare REIT SBRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-110,514
| Closed | -$1.92M | – | 1018 |
|
|
2020
Q4 | $1.92M | Buy |
110,514
+494
| +0.4% | +$7.88K | 0.03% | 650 |
|
|
2020
Q3 | $1.52M | Sell |
110,020
-2,626
| -2% | -$38.6K | 0.03% | 651 |
|
|
2020
Q2 | $1.63M | Buy |
112,646
+3,464
| +3% | +$45.5K | 0.03% | 606 |
|
|
2020
Q1 | $1.19M | Buy |
109,182
+6,156
| +6% | +$114K | 0.03% | 658 |
|
|
2019
Q4 | $2.2M | Buy |
103,026
+3,640
| +4% | +$81.5K | 0.04% | 543 |
|
|
2019
Q3 | $2.28M | Buy |
99,386
+3,709
| +4% | +$79.1K | 0.05% | 482 |
|
|
2019
Q2 | $1.88M | Buy |
95,677
+850
| +0.9% | +$16.6K | 0.04% | 591 |
|
|
2019
Q1 | $1.85M | Buy |
94,827
+1,441
| +2% | +$27.3K | 0.04% | 635 |
|
|
2018
Q4 | $1.54M | Buy |
93,386
+1,818
| +2% | +$36.6K | 0.04% | 615 |
|
|
2018
Q3 | $2.12M | Buy |
91,568
+130
| +0.1% | +$2.94K | 0.04% | 532 |
|
|
2018
Q2 | $1.99M | Buy |
91,438
+1,918
| +2% | +$37.5K | 0.04% | 553 |
|
|
2018
Q1 | $1.58M | Buy |
89,520
+1,711
| +2% | +$30.2K | 0.04% | 650 |
|
|
2017
Q4 | $1.65M | Buy |
87,809
+536
| +0.6% | +$10.7K | 0.04% | 649 |
|
|
2017
Q3 | $1.92M | Buy |
87,273
+71,173
| +442% | +$1.61M | 0.05% | 534 |
|
|
2017
Q2 | $388K | Buy |
16,100
+834
| +5% | +$21.2K | 0.01% | 1069 |
|
|
2017
Q1 | $426K | Buy |
15,266
+1,005
| +7% | +$26.4K | 0.01% | 1024 |
|
|
2016
Q4 | $348K | Buy |
14,261
+820
| +6% | +$18.8K | 0.01% | 1067 |
|
|
2016
Q3 | $338K | Buy |
13,441
+681
| +5% | +$16.3K | 0.01% | 1040 |
|
|
2016
Q2 | $263K | Buy |
12,760
+1,172
| +10% | +$24.4K | 0.01% | 1081 |
|
|
2016
Q1 | $233K | Buy |
11,588
+1,090
| +10% | +$20.9K | 0.01% | 1086 |
|
|
2015
Q4 | $212K | Buy |
10,498
+902
| +9% | +$19K | 0.01% | 1089 |
|
|
2015
Q3 | $222K | Buy |
9,596
+1,414
| +17% | +$36.1K | 0.01% | 1046 |
|
|
2015
Q2 | $211K | Buy |
8,182
+317
| +4% | +$9K | 0.01% | 1067 |
|
|
2015
Q1 | $261K | Buy |
7,865
+850
| +12% | +$27.6K | 0.01% | 1003 |
|
|
2014
Q4 | $213K | Buy |
7,015
+1,117
| +19% | +$30.8K | ﹤0.01% | 1476 |
|
|
2014
Q3 | $143K | Sell |
5,898
-43
| -0.7% | -$1.19K | ﹤0.01% | 1576 |
|
|
2014
Q2 | $171K | Buy |
5,941
+1,187
| +25% | +$34.5K | ﹤0.01% | 1511 |
|
|
2014
Q1 | $133K | Sell |
4,754
-1,272
| -21% | -$34.9K | ﹤0.01% | 1557 |
|
|
2013
Q4 | $158K | Buy |
6,026
+537
| +10% | +$13.8K | ﹤0.01% | 1587 |
|
|
2013
Q3 | $126K | Buy |
5,489
+316
| +6% | +$7.79K | ﹤0.01% | 1455 |
|
|
2013
Q2 | $135K | Buy |
+5,173
| New | +$149K | ﹤0.01% | 1336 |
|
Other funds holding SBRA
AAMU
CIM
Mason Street Advisors's SBRA Position: Q1 2021 in Review
Mason Street Advisors sold out of Sabra Healthcare REIT (SBRA) in Q1 2021, closing a stake of 110,514 shares — an estimated $1.92M sold.
Mason Street Advisors first reported a position in SBRA in Q2 2013 and held it in 31 quarters. The position peaked at $2.28M in Q3 2019. 333 funds tracked by Wall St. Rank hold SBRA as of Q1 2021.
- Mason Street Advisors reported no remaining Sabra Healthcare REIT position as of Q1 2021 after selling out during the quarter.
- Mason Street Advisors sold 110,514 Sabra Healthcare REIT shares in Q1 2021, an estimated $1.92M.
- Mason Street Advisors first reported a position in Sabra Healthcare REIT in Q2 2013 and held it in 31 quarters.
- Mason Street Advisors's Sabra Healthcare REIT position peaked at $2.28M in Q3 2019.
- 333 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q1 2021.
Based on Mason Street Advisors's 13F filing for Q1 2021, filed 14 May 2021.